contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


rls-global-ab-publ-interim-report-q3-2022

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

RLS Global

JULY 1st - SEPTEMBER 30th (Previous year in brackets)Net sales amounted to TSEK 198 (TSEK 132).Earnings before interest and taxes (EBIT) amounted to MSEK -5,2 (MSEK 6,2).Earnings per share after...

JULY 1st - SEPTEMBER 30th (Previous year in brackets)<ul><li>Net sales amounted to TSEK 198 (TSEK 132).</li><li>Earnings before interest and taxes (EBIT) amounted to MSEK -5,2 (MSEK 6,2).</li><li>Earnings per share after dilution at SEK -0,07 (SEK 0,09).</li><li>Cash flow from operating activities amounted to TSEK -5 114 (TSEK -6 214).</li><li>Liquid assets at the end of the period MSEK 3,7 (MSEK 16,4).</li><li>Equity ratio was 77 % (86 %).</li></ul>JANUARY 1st-SEPTEMBER 30th (Previous year in brackets)<ul><li>Net sales amounted to TSEK 904 (TSEK 472).</li><li>Earnings before interest and taxes (EBIT) amounted to MSEK -16,4 (MSEK 3,98).</li><li>Earnings per share after dilution at SEK -0,23 (SEK 0,06).</li><li>Cash flow from operating activities amounted to MSEK -12,7 (MSEK -3,46).</li><li>Liquid assets at the end of the period MSEK 3,7 (MSEK 16,4).</li><li>Equity ratio was 77 % (86 %).</li></ul>Summary of events during third quarter<ul><li>RLS issues new shares by way of set-off, totaling TSEK 10 000.</li><li>An article regarding ChloraSolv is published in Journal of Wound Care.</li></ul>Summary of events after third quarteR<ul><li>New CEO Björn Larsson starts October 1.</li><li>RLS has raised liquid assets through a new issue in November 2022 (rights issue) of MSEK 29.4.</li><li>The Swedish Medicines Agency has approved RLS' application for pressure ulcers.</li><li>RLS visits the conference Wounds UK in Harrogate, England.</li></ul>The Interim Report Q3, 2022, is enclosed and is also available here&nbsp;(<a href="https://rls.global/financial-information/financial-reports-eng/">https://rls.global/financial-information/financial-reports-eng/</a>).Publication This information was submitted for publication through the agency of the below contact person,at 08.00 CET on November 24, 2022.